Eden tirzepatide: November 2026 price and position
As of November 20, 2026, Eden charges $129 a month for compounded tirzepatide month to month, all-in, according to its own page. Over a year at that price you would pay $1,548 (12 months).
Released · Last reviewed · how we verify
Eden tirzepatide prices, read November 20, 2026
| Measure | Amount | Basis |
|---|---|---|
| Month to month, all-in | $129 | per month |
| Lowest printed rate | $129 | every month |
| 3 months at the month-to-month price | $387 | 3 monthly charges |
| 6 months at the month-to-month price | $774 | 6 monthly charges |
| 12 months at the month-to-month price | $1,548 | 12 monthly charges |
Where Eden sits
Among the 12 compounded programs in this dataset that print a month-to-month tirzepatide price that applies at every dose or at the maintenance dose, the median is $234 and the range runs from $85.58 (Collective) to $399 (Remedy Meds). Price check: 2 of them cost less over a year at their month-to-month price, among them Collective ($85.58 a month), Mondae ($126 a month). Programs whose page shows only a starting-dose or coupon price are left out of this comparison, because their maintenance-dose month cannot be confirmed.
FDA warning letters
FDA’s warning-letter index lists warning letter 728279 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to Eden; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.
Limitations and what to check before you enroll
Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound; it is made for an individual patient by a state-licensed pharmacy. Ask Eden for the all-in price at the maintenance dose, what is charged today and how often, and which pharmacy fills the prescription. A clinician decides whether any GLP-1 is right for you.
Frequently asked
How much does Eden charge for tirzepatide?
As of November 20, 2026, Eden charges $129 a month for compounded tirzepatide month to month, all-in, according to its own page. Over a year at that price you would pay $1,548 (12 months).
Is Eden’s tirzepatide FDA-approved?
No. Compounded tirzepatide from any telehealth program, Eden included, is not FDA-approved and is not the same product as Zepbound or Mounjaro. It is made for an individual patient by a state-licensed compounding pharmacy. Brand Zepbound is the FDA-approved version.
Where do these Eden figures come from?
From Eden’s own page (first-party read, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- Zepbound (tirzepatide) prescribing information on DailyMed (read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- Eden pricing page (read November 20, 2026)
- FDA warning letter 728279 to Eden (dated 2026-06-08, posted 2026-06-16; read November 20, 2026)